Cargando…

Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children

BACKGROUND: Protease inhibitors (PIs) have been associated with metabolic complications. There is a trend to switch to simpler therapy to improve these disturbances. We report a case-series describing the effects in metabolic abnormalities in seven HIV-infected children, previously treated with prot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonzalez-Tome, M Isabel, Amador, Jose Tomas Ramos, Peña, M Jose Mellado, Gomez, M Luisa Navarro, Conejo, Pablo Rojo, Fontelos, Pablo Martin
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584640/ https://www.ncbi.nlm.nih.gov/pubmed/18945352 http://dx.doi.org/10.1186/1471-2334-8-144

Ejemplares similares

Lipid and glucose alterations in perinatally-acquired HIV-infected adolescents and young adults
por: Blázquez, Daniel, et al.
Publicado: (2015)

Prognostic factors of a lower CD4/CD8 ratio in long term viral suppression HIV infected children
por: Guillén, Sara, et al.
Publicado: (2019)

The impact of nevirapine- versus protease inhibitor-based regimens on virological markers of HIV-1 persistence during seemingly suppressive ART
por: Kiselinova, Maja, et al.
Publicado: (2014)

2'-Deoxythymidine Adducts from the Anti-HIV Drug Nevirapine
por: Antunes, Alexandra M. M., et al.
Publicado: (2013)

Pharmacological and clinical evidence of nevirapine immediate- and extended-release formulations
por: Ena, Javier, et al.
Publicado: (2012)

Twelfth-Position Deuteration of Nevirapine Reduces 12-Hydroxy-Nevirapine Formation and Nevirapine-Induced Hepatocyte Death
por: Heck, Carley J. S., et al.
Publicado: (2020)

Pregnancy outcomes in perinatally HIV-infected young women in Madrid, Spain: 2000-2015
por: Prieto, Luis M., et al.
Publicado: (2017)

Nevirapine Resistance and Breast-Milk HIV Transmission: Effects of Single and Extended-Dose Nevirapine Prophylaxis in Subtype C HIV-Infected Infants
por: Moorthy, Anitha, et al.
Publicado: (2009)

Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children
por: Larru, Beatriz, et al.
Publicado: (2007)

Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia
por: Llibre, Josep M., et al.
Publicado: (2015)

Nevirapine induced exfoliative dermatitis in an HIV-infected patient
por: Bhandarkar, Anoosha P., et al.
Publicado: (2011)

Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis
por: Permar, Sallie R, et al.
Publicado: (2013)

Impact of long-term viral suppression in CD4+ recovery of HIV-children on Highly Active Antiretroviral Therapy
por: Resino, Salvador, et al.
Publicado: (2006)

Covalent Histone Modification by an Electrophilic Derivative of the Anti-HIV Drug Nevirapine
por: Harjivan, Shrika G., et al.
Publicado: (2021)

New diagnoses of human immunodeficiency virus infection in the Spanish pediatric HIV Cohort (CoRISpe) from 2004 to 2013
por: Jiménez de Ory, Santiago, et al.
Publicado: (2017)

Effect of HIV/HCV Co-Infection on the Protease Evolution of HIV-1B: A Pilot Study in a Pediatric Population
por: Domínguez-Rodríguez, Sara, et al.
Publicado: (2018)

Sociodemographic changes and trends in the rates of new perinatal HIV diagnoses and transmission in Spain from 1997 to 2015
por: Jiménez de Ory, Santiago, et al.
Publicado: (2019)

Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients
por: Macías, J, et al.
Publicado: (2010)

Nevirapine induced Stevens–Johnson syndrome in an HIV infected patient
por: Singh, Harminder, et al.
Publicado: (2011)

Adverse Events in a Cohort of HIV Infected Pregnant and Non-Pregnant Women Treated with Nevirapine versus Non-Nevirapine Antiretroviral Medication
por: Aaron, Erika, et al.
Publicado: (2010)

Incidence and Determinants of Nevirapine and Efavirenz-Related Skin Rashes in West Africans: Nevirapine's Epitaph?
por: Sarfo, Fred Stephen, et al.
Publicado: (2014)

Solid-State Characterization of Nevirapine
por: Sarkar, Mahua, et al.
Publicado: (2008)

Co-administration of fluconazole increases nevirapine concentrations in HIV-infected Ugandans
por: Wakeham, Katie, et al.
Publicado: (2010)

Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole
por: Manosuthi, Weerawat, et al.
Publicado: (2007)

Effectiveness and tolerability of abacavir-lamivudine-nevirapine (ABC/3TC/NVP) in a multicentre cohort of HIV-infected, ARV-naïve patients
por: Podzamczer, Daniel, et al.
Publicado: (2014)

Cutaneous drug-reactions to nevirapine: study of risk factors in 268 HIV-infected patients
por: Badaoui, L, et al.
Publicado: (2014)

Development of a liposomal nanodelivery system for nevirapine
por: Ramana, Lakshmi N, et al.
Publicado: (2010)

Population pharmacokinetic and pharmacogenetic analysis of nevirapine in hypersensitive and tolerant HIV-infected patients from Malawi
por: Dickinson, L, et al.
Publicado: (2010)

Association of Nevirapine Levels with Rash or Hepatotoxicity Among HIV-Infected Thai Women
por: Ratanasuwan, Winai, et al.
Publicado: (2012)

Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship
por: Bhatt, Nilesh B., et al.
Publicado: (2015)

Nevirapine-induced Stevens-Johnson syndrome in children living with HIV in South Africa
por: du Toit, Jacques D., et al.
Publicado: (2021)

Preparation and Characterisation of Nevirapine Oral Nanosuspensions
por: Raju, Anju, et al.
Publicado: (2014)

Pregnancy Outcomes Among Perinatally HIV-Infected Women in Spain
por: Nogueira López, Javier, et al.
Publicado: (2022)

Targeting the Gut Microbiota of Vertically HIV-Infected Children to Decrease Inflammation and Immunoactivation: A Pilot Clinical Trial
por: Sainz, Talía, et al.
Publicado: (2022)

Efficacy and safety of switching from nevirapine immediate-release twice daily to nevirapine extended-release once daily in virologically suppressed HIV-infected patients: a retrospective cohort study in Taiwan
por: Lee, Chun-Yuan, et al.
Publicado: (2017)

Development of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, Mozambique
por: Antunes, Francisco, et al.
Publicado: (2015)

Investigating the continuous synthesis of a nicotinonitrile precursor to nevirapine
por: Longstreet, Ashley R, et al.
Publicado: (2013)

HLA involvement in nevirapine-induced dermatological reaction in antiretroviral-treated HIV-1 patients
por: Umapathy, Shankarkumar, et al.
Publicado: (2011)

HIV-1 reverse transcriptase complex with DNA and nevirapine reveals nonnucleoside inhibition mechanism
por: Das, Kalyan, et al.
Publicado: (2012)

Nevirapine Plasma Concentrations Are Associated with Virologic Response and Hepatotoxicity in Chinese Patients with HIV Infection
por: Wang, Jia, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_f9iqhihuruhv4a5v0ln9lqk0sj